Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Incorporate a hardware wallet into your security plan, plus complementary practices to reduce exposure and strengthen protection.
19,310 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Institutional buyers poured $23.25 million into SOL and XRP ETFs on March 4, 2026, signaling a shift toward altcoins ...
A fresh analysis pegs the average 65-year-old's long-term care fund at $135,000 for high-intensity needs, with notabl...
Rocket Lab’s stock faced a sharp pullback before rebounding in March. This article breaks down what caused the drop, ...
Kalshi and Polymarket are reportedly exploring rounds that could push each platform toward $20 billion valuations, up...
Three AWS data centers in the UAE and Bahrain were hit by Iranian drones, causing widespread outages in finance and d...
When a major fund manager trims a stake in a top municipal income fund, it sparks questions about risk, yields, and s...
International equities are outperforming U.S. stocks in early 2026, with VXUS leading the charge. The shift has many ...
If you’re building a simple, durable plan, understanding three core ideas around VOO can save you money and stress. T...
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
A recent SEC filing shows Tabor Asset Management increasing its stake in Madison Square Garden Sports, underscoring a...
When a packaging company posts stronger results, investors take notice. This piece explains why karat packaging stock...